Skip to main content
Erschienen in: Clinical Rheumatology 7/2019

06.03.2019 | Original Article

Validation of Turkish version of the Scleroderma Health Assessment Questionnaire

verfasst von: Duygu Temiz Karadag, Fatih Karakas, Senem Tekeoglu, Ayten Yazici, Ozlem Ozdemir Isik, Ayse Cefle

Erschienen in: Clinical Rheumatology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The Scleroderma Health Assessment Questionnaire (SHAQ) is a functional scale which consists of five scleroderma-specific items (overall disease severity, Raynaud’s phenomenon, digital ulcers, respiratory and intestinal involvement) in addition to Health Assessment Questionnaire Disability Index (HAQ-DI). The objective of this study was to perform an adaptation and validation of a Turkish version of the SHAQ.

Method

We validated psychometric properties of the scale with 70 consecutive systemic sclerosis (SSc) patients, who fulfilled the 2013 ACR/EULAR classification criteria for SSc. We evaluated test–retest reliability with the intraclass correlation coefficient (ICC), discriminant validity by stratifying patients according to organ involvements and disease subtypes, and convergent validity by testing the correlation between SHAQ and related components of Short Form 36 version 2 (SF-36v2). Internal consistency of the questionnaire was evaluated by Cronbach’s alpha coefficient.

Results

The SHAQ-global, visual analogue scales (VAS) of pulmonary, digital ulcer, and Raynaud’s phenomenon were significantly correlated with the physical component score of the SF-36v2 (r = − 0.274, r = − 0.295, r = − 0.326, r = − 0.308, p < 0.05, respectively) for the convergent validity. The instruments could not discriminate between disease subtypes, except the digital ulcer VAS which was significantly higher in patients with dcSSc (1.00 ± 0.93 vs 0.55 ± 0.88, p = 0.026) for the discriminant validity. The HAQ-DI, SHAQ-global, digital ulcer VAS, and pulmonary VAS showed moderate correlation with an increase in the number of the organs involved (r = 0.319, r = 0.329, r = 0.341, r = 0.278, p < 0.05, respectively). We demonstrated high reproducibility for HAQ-DI (ICC = 0.962, 95% confidence interval = 0.934–0.978) and the other items of SHAQ. The overall internal consistency of the SHAQ was satisfactory (Cronbach’s alpha = 0.953).

Conclusions

The Turkish version of the SHAQ met the requirements of validity and reproducibility.
Literatur
1.
2.
Zurück zum Zitat Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M (2009) Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 36:768–772CrossRefPubMed Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M (2009) Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 36:768–772CrossRefPubMed
4.
Zurück zum Zitat Silman A, Akesson A, Newman J, Henriksson H, Sandquist G, Nihill M, Palfrey S, Lomas R, Wollheim F, Black C (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83PubMed Silman A, Akesson A, Newman J, Henriksson H, Sandquist G, Nihill M, Palfrey S, Lomas R, Wollheim F, Black C (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83PubMed
5.
Zurück zum Zitat Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P (1995) Concurrent validity of the Health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 8:189–193CrossRefPubMed Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P (1995) Concurrent validity of the Health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 8:189–193CrossRefPubMed
6.
7.
Zurück zum Zitat Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate a change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991CrossRefPubMed Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate a change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991CrossRefPubMed
8.
Zurück zum Zitat Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y, Hatamochi A, Kondo H, Takehara K (2003) Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol 30:1253–1258PubMed Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y, Hatamochi A, Kondo H, Takehara K (2003) Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol 30:1253–1258PubMed
9.
Zurück zum Zitat Rocha LF, Marangoni RG, Sampaio-Barros PD, Levy-Neto M, Yoshinari NH, Bonfa E, Steen V, Kowalski SC (2014) Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ). Clin Rheumatol 33:699–706CrossRefPubMed Rocha LF, Marangoni RG, Sampaio-Barros PD, Levy-Neto M, Yoshinari NH, Bonfa E, Steen V, Kowalski SC (2014) Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ). Clin Rheumatol 33:699–706CrossRefPubMed
10.
Zurück zum Zitat Ng X, Thumboo J, Low AH (2012) Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 15:268–276CrossRefPubMed Ng X, Thumboo J, Low AH (2012) Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 15:268–276CrossRefPubMed
11.
Zurück zum Zitat Johnson SR, Hawker GA, Davis AM (2005) The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 53:256–262CrossRefPubMed Johnson SR, Hawker GA, Davis AM (2005) The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 53:256–262CrossRefPubMed
12.
Zurück zum Zitat Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, Marjanovic Z, Heneggar C, Papo T, Crickx B, Sereni D, Cabane J, Farge D (2005) Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24:3–10CrossRefPubMed Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, Marjanovic Z, Heneggar C, Papo T, Crickx B, Sereni D, Cabane J, Farge D (2005) Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24:3–10CrossRefPubMed
13.
Zurück zum Zitat van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2003) Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRef van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2003) Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRef
14.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1998) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205 LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1998) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
15.
Zurück zum Zitat Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed
16.
Zurück zum Zitat Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR (2008) Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35:458–465PubMed Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR (2008) Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35:458–465PubMed
17.
Zurück zum Zitat Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A (2004) Issues in cross-cultural validity: an example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 51:14–19CrossRefPubMed Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A (2004) Issues in cross-cultural validity: an example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 51:14–19CrossRefPubMed
18.
Zurück zum Zitat Celik D, Coban Ö (2016) Short Form Health Survey version-2.0 Turkish (SF-36v2) is an efficient outcome parameter in musculoskeletal research. Acta Orthop Traumatol Turc 50:558–561CrossRefPubMedPubMedCentral Celik D, Coban Ö (2016) Short Form Health Survey version-2.0 Turkish (SF-36v2) is an efficient outcome parameter in musculoskeletal research. Acta Orthop Traumatol Turc 50:558–561CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 25:3186–3191CrossRef Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 25:3186–3191CrossRef
20.
Zurück zum Zitat Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104CrossRef Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104CrossRef
21.
Zurück zum Zitat Fayers PM, Machin D (2007) Scores and measurements: validity, reliability, sensitivity. In: Quality of life: the assessment, analysis, and interpretation of patient-reported outcomes, 2nd edn. John Wiley & Sons, Chichester, pp 77–107CrossRef Fayers PM, Machin D (2007) Scores and measurements: validity, reliability, sensitivity. In: Quality of life: the assessment, analysis, and interpretation of patient-reported outcomes, 2nd edn. John Wiley & Sons, Chichester, pp 77–107CrossRef
22.
Zurück zum Zitat Cohen J (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum L Associates, Mahwah, p 703 Cohen J (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum L Associates, Mahwah, p 703
23.
Zurück zum Zitat Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Relaxin Study Group, Scleroderma Clinical Trials Consortium et al (2005) Responsiveness of the SF-36v2 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 32:832–840PubMed Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Relaxin Study Group, Scleroderma Clinical Trials Consortium et al (2005) Responsiveness of the SF-36v2 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 32:832–840PubMed
24.
Zurück zum Zitat Pope J (2011) Measures of systemic sclerosis (scleroderma). Arthritis Care Res (Hoboken) 63:S98–S111CrossRef Pope J (2011) Measures of systemic sclerosis (scleroderma). Arthritis Care Res (Hoboken) 63:S98–S111CrossRef
Metadaten
Titel
Validation of Turkish version of the Scleroderma Health Assessment Questionnaire
verfasst von
Duygu Temiz Karadag
Fatih Karakas
Senem Tekeoglu
Ayten Yazici
Ozlem Ozdemir Isik
Ayse Cefle
Publikationsdatum
06.03.2019
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 7/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04494-5

Weitere Artikel der Ausgabe 7/2019

Clinical Rheumatology 7/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.